1
|
Liao XM and Leung KN: Indirubin-3′-oxime
induces mitochondrial dysfunction and triggers growth inhibition
and cell cycle arrest in human neuroblastoma cells. Oncol Rep.
29:371–379. 2013.
|
2
|
Shen H, Xu W, Chen Q, Wu Z, Tang H and
Wang F: Tetrandrine prevents acquired drug resistance of K562 cells
through inhibition of mdr1 gene transcription. J Cancer Res Clin
Oncol. 136:659–665. 2010. View Article : Google Scholar : PubMed/NCBI
|
3
|
Yuan Y, Shen H, Hu XY, Gu FY, Li MD and
Zhong X: Multidisciplinary treatment with chemotherapy, targeted
drug, and high-intensity focused ultrasound in advanced pancreatic
carcinoma. Med Oncol. 29:957–961. 2012. View Article : Google Scholar : PubMed/NCBI
|
4
|
Ma B, Chai S, Li N, To KK, Kan WL, Yang D
and Lin G: Reversal of P-glycoprotein-mediated multidrug resistance
by a synthetic α-aminoxy peptidomimetic. Int J Pharm. 424:33–39.
2012.
|
5
|
Marin A, Sun H, Husseini GA, Pitt WG,
Christensen DA and Rapoport NY: Drug delivery in pluronic micelles:
effect of high-frequency ultrasound on drug release from micelles
and intracellular uptake. J Control Release. 84:39–47. 2002.
View Article : Google Scholar : PubMed/NCBI
|
6
|
Feng Y, Tian ZM, Wan MX and Zheng ZB: Low
intensity ultrasound-induced apoptosis in human gastric carcinoma
cells. World J Gastroenterol. 14:4873–4879. 2008. View Article : Google Scholar : PubMed/NCBI
|
7
|
Man J, Shelton RM, Cooper PR and Scheven
BA: Low-intensity low-frequency ultrasound promotes proliferation
and differentiation of odontoblast-like cells. J Endod. 38:608–613.
2012. View Article : Google Scholar : PubMed/NCBI
|
8
|
Rapoport N: Combined cancer therapy by
micellar-encapsulated drug and ultrasound. Int J Pharm.
277:155–162. 2004. View Article : Google Scholar : PubMed/NCBI
|
9
|
Liu Y, Cho CW, Yan X, Henthorn TK,
Lillehei KO, Cobb WN and Ng KY: Ultrasound-induced hyperthermia
increases cellular uptake and cytotoxicity of P-glycoprotein
substrates in multi-drug resistant cells. Pharm Res. 18:1255–1261.
2001. View Article : Google Scholar : PubMed/NCBI
|
10
|
Cho CW, Liu Y, Cobb WN, Henthorn TK,
Lillehei K, Christians U and Ng KY: Ultrasound-induced mild
hyperthermia as a novel approach to increase drug uptake in brain
microvessel endothelial cells. Pharm Res. 19:1123–1129. 2002.
View Article : Google Scholar : PubMed/NCBI
|
11
|
Yu T, Hu K, Bai J and Wang Z: Reversal of
adriamycin resistance in ovarian carcinoma cell line by combination
of verapamil and low-level ultrasound. Ultrason Sonochem. 10:37–40.
2003. View Article : Google Scholar : PubMed/NCBI
|
12
|
Yu T, Huang X, Hu K, Bai J and Wang Z:
Mechanisms of reversal of adriamycin resistance in human ovarian
carcinoma cell line by ultrasound. Int J Gynecol Cancer. 14:76–81.
2004. View Article : Google Scholar : PubMed/NCBI
|
13
|
Zhao L, Jin X, Xu Y, Guo Y, Liang R, Guo
Z, Chen T, Sun Y and Ding X: Functional study of the novel
multidrug resistance gene HA117 and its comparison to multidrug
resistance gene 1. J Exp Clin Cancer Res. 29:98–105. 2010.
View Article : Google Scholar : PubMed/NCBI
|
14
|
Luo J, Deng ZL, Luo X, Tang N, Song WX,
Chen J, Sharff KA, Luu HH, Haydon RC, Kinzler KW, Vogelstein B and
He TC: A protocol for rapid generation of recombinant adenoviruses
using the AdEasy system. Nat Protoc. 2:1236–1247. 2007. View Article : Google Scholar : PubMed/NCBI
|
15
|
Zhao L, Sun Y, Li X, Jin X, Xu Y, Guo Z,
Liang R, Ding X, Chen T and Wang S: Multidrug resistance strength
of the novel multidrug resistance gene HA117: compared with MRP1.
Med Oncol. 28:1188–1195. 2011. View Article : Google Scholar : PubMed/NCBI
|
16
|
Xia CY, Liu YH, Wang P and Xue YX:
Low-frequency ultrasound irradiation increases blood-tumor barrier
permeability by transcellular pathway in a rat glioma model. J Mol
Neurosci. 48:281–290. 2012. View Article : Google Scholar : PubMed/NCBI
|
17
|
O’Reilly MA, Waspe AC, Ganguly M and
Hynynen K: Focused-ultrasound disruption of the blood-brain barrier
using closely-timed short pulses: influence of sonication
parameters and injection rate. Ultrasound Med Biol. 37:587–594.
2011.
|
18
|
McDannold N, Vykhodtseva N and Hynynen K:
Effects of acoustic parameters and ultrasound contrast agent dose
on focused-ultrasound induced blood-brain barrier disruption.
Ultrasound Med Biol. 34:930–937. 2008. View Article : Google Scholar : PubMed/NCBI
|
19
|
Hayashi S, Yamamoto M, Tachibana K, Ueno
Y, Bu G and Fukushima T: Mechanism of photofrin-enhanced
ultrasound-induced human glioma cell death. Anticancer Res.
29:897–905. 2009.PubMed/NCBI
|
20
|
Jemal A, Siegel R, Xu J and Ward E: Cancer
statistics, 2010. CA Cancer J Clin. 60:277–300. 2010. View Article : Google Scholar
|
21
|
Lazaris AC, Kavantzas NG, Zorzos HS,
Tsavaris NV and Davaris PS: Markers of drug resistance in relapsing
colon cancer. J Cancer Res Clin Oncol. 128:114–118. 2002.
View Article : Google Scholar : PubMed/NCBI
|
22
|
Berger W, Setinek U, Hollaus P, Zidek T,
Steiner E, Elbling L, Cantonati H, Attems J, Gsur A and Micksche M:
Multidrug resistance markers P-glycoprotein, multidrug resistance
protein 1, and lung resistance protein in non-small cell lung
cancer: prognostic implications. J Cancer Res Clin Oncol.
131:355–363. 2005. View Article : Google Scholar
|
23
|
Sui H, Fan ZZ and Li Q: Signal
transduction pathways and transcriptional mechanisms of
ABCB1/Pgp-mediated multiple drug resistance in human cancer cells.
J Int Med Res. 40:426–435. 2012. View Article : Google Scholar : PubMed/NCBI
|
24
|
Satava RM: Advanced technologies and the
future of medicine and surgery. Yonsei Med J. 49:873–878. 2008.
View Article : Google Scholar
|
25
|
Orsi F, Arnone P, Chen W and Zhang L: High
intensity focused ultrasound ablation: a new therapeutic option for
solid tumors. J Can Res Ther. 6:414–420. 2010. View Article : Google Scholar : PubMed/NCBI
|
26
|
Zini C, Hipp E, Thomas S, Napoli A,
Catalano C and Oto A: Ultrasound- and MR-guided focused ultrasound
surgery for prostate cancer. World J Radiol. 4:247–252. 2012.
View Article : Google Scholar : PubMed/NCBI
|
27
|
Xu G, Luo G, He L, Li J, Shan H, Zhang R,
Li Y, Gao X, Lin S and Wang G: Follow-up of high-intensity focused
ultrasound treatment for patients with hepatocellular carcinoma.
Ultrasound Med Biol. 37:1993–1999. 2011. View Article : Google Scholar : PubMed/NCBI
|
28
|
Mougenot C, Köhler MO, Enholm J, Quesson B
and Moonen C: Quantification of near-field heating during
volumetric MR-HIFU ablation. Med Phys. 38:272–282. 2011.PubMed/NCBI
|
29
|
Hung HY, Ohkoshi E, Goto M, Bastow KF,
Nakagawa-Goto K and Lee KH: Antitumor agents. 293 Nontoxic
dimethyl-4,4′-dimethoxy-5,6,5′,6′-dimethylenedioxybiphenyl-2,2′-dicarboxylate
(DDB) analogues chemosensitize multidrug-resistant cancer cells to
clinical anticancer drugs. J Med Chem. 55:5413–5424.
2012.PubMed/NCBI
|
30
|
Tang X, Gu X, Ren Z, Ma Y, Lai Y, Peng H,
Peng S and Zhang Y: Synthesis and evaluation of substituted
dibenzo[c,e]azepine-5-ones as P-glycoprotein-mediated multidrug
resistance reversal agents. Bioorg Med Chem Lett. 22:2675–2680.
2012.
|
31
|
Scheven BA, Millard JL, Cooper PR, Lea SC,
Walmsley AD and Smith AJ: Short-term in vitro effects of low
frequency ultrasound on odontoblast-like cells. Ultrasound Med
Biol. 33:1475–1482. 2007. View Article : Google Scholar : PubMed/NCBI
|
32
|
Hassan MA, Buldakov MA, Ogawa R, Zhao QL,
Furusawa Y, Kudo N, Kondo T and Riesz P: Modulation control over
ultrasound-mediated gene delivery: evaluating the importance of
standing waves. J Control Release. 141:70–76. 2010. View Article : Google Scholar : PubMed/NCBI
|
33
|
Zhang H, Jiang H, Wang H, Zhao J, Chen B
and Wang X: Ultrasound mediated drug-loaded nanoparticles crossing
cell membranes as a new strategy to reverse cancer multidrug
resistance. J Nanosci Nanotechnol. 11:1834–1840. 2011. View Article : Google Scholar : PubMed/NCBI
|
34
|
Huang Q, Deng J, Xie Z, Wang F, Chen S,
Lei B, Liao P, Huang N, Wang Z, Wang Z and Cheng Y: Effective gene
transfer into central nervous system following
ultrasound-microbubbles- induced opening of the blood-brain
barrier. Ultrasound Med Biol. 38:1234–1243. 2012. View Article : Google Scholar : PubMed/NCBI
|